Pancreatic neuroendocrine tumor (pNET), well-differentiated G1/G2 · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	standard
Linked regimen	`None`

ID	`IND-MEN1-SUSPICION-PREVENTION-GENETIC-COUNSELING`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-PNET`
Sources	`SRC-NCCN-NET-2025`

Notes

STUB — v0.2-B hereditary pilot (MEN1, additional). Thakker JCEM 2012 Clinical Practice Guidelines for MEN1 + ESE-2024 MEN1 update as new SRC entities are v0.2-B authoring backlog. Two-Co-Lead signoff queued.

Used By

Red flag

RF-MEN1-FAMILY-HISTORY-SUSPICION - Family pedigree suggestive of Multiple Endocrine Neoplasia type 1 (MEN1, Wermer syndrome)...